drugset / Trial / NCT07598968
Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of HL1113-R1 and HL1113-R2 in Healthy Adult Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
This clinical trial is a two-arm, open-label, single-sequence, multiple oral dosings, cross-over design clinical trial to evaluate the safety and pharmacokinetic characteristics of HL1113-R1 and HL1113-R2 in healthy adult volunteers
Timeline
- Start
- 2023-06-18
- Primary completion
- 2023-07-12
- Completion
- 2023-07-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HL1113R1 | Unknown | — | Oral |
| Subject | HL1113R2 | Unknown | — | Oral |